| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Undine Lang | Q5394305 |
| P2093 | author name string | Daniel J Muller | |
| Nathalie Strutz-Seebohm | |||
| Jurgen Gallinat | |||
| Imke Puls | |||
| P2860 | cites work | Glutamate AMPA receptor subunit 1 gene (GRIA1) and DSM-IV-TR schizophrenia: a pilot case-control association study in an Italian sample | Q46982053 |
| Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain | Q47378030 | ||
| Association study of -1727 A/T, -50 C/T and (CAA)n repeat GSK-3beta gene polymorphisms with schizophrenia | Q47390678 | ||
| Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia | Q48411170 | ||
| Low GSK-3 activity in frontal cortex of schizophrenic patients | Q48752142 | ||
| Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology. | Q51953367 | ||
| Schizotypal dimensions: An intermediate phenotype associated with the COMT high activity allele | Q57698054 | ||
| Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia | Q24293245 | ||
| Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia | Q24308818 | ||
| Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia | Q24532517 | ||
| Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample | Q24540539 | ||
| Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia | Q24612644 | ||
| Prenatal infection as a risk factor for schizophrenia | Q24644310 | ||
| The regulator of G protein signaling family | Q28145604 | ||
| Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia | Q28239401 | ||
| Association study of polymorphisms in the glutamate transporter genes SLC1A1, SLC1A3, and SLC1A6 with schizophrenia | Q28283245 | ||
| Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia | Q28568230 | ||
| A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development | Q28582746 | ||
| A polygenic theory of schizophrenia | Q28972276 | ||
| Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia | Q29614929 | ||
| Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence | Q29618819 | ||
| Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses | Q29618915 | ||
| The neuropathology of schizophrenia. A critical review of the data and their interpretation | Q30573678 | ||
| Association of the DTNBP1 locus with schizophrenia in a U.S. population | Q33910454 | ||
| Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria | Q33977974 | ||
| Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology | Q33991750 | ||
| Novel neurotransmitters and their neuropsychiatric relevance | Q34073604 | ||
| Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p. | Q34137538 | ||
| The molecular genetics of schizophrenia: new findings promise new insights | Q35569496 | ||
| Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders | Q36499391 | ||
| The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia | Q38333775 | ||
| Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin | Q38403090 | ||
| Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey | Q39435279 | ||
| Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing | Q42167781 | ||
| A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder | Q42675472 | ||
| Polymorphisms of dopamine receptors and tardive dyskinesia among Chinese patients with schizophrenia | Q44259395 | ||
| The influence of typical and atypical neuroleptic drugs in the production of interleukin-2 and interferon-gamma in vitro | Q44302488 | ||
| Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. | Q46022290 | ||
| Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory | Q46113483 | ||
| Failure to confirm association between RGS4 haplotypes and schizophrenia in Caucasians | Q46355088 | ||
| Mutational screening and association study of glutamate decarboxylase 1 as a candidate susceptibility gene for bipolar affective disorder and schizophrenia | Q46418599 | ||
| Dopamine D3 receptors as a novel target for improving the treatment of schizophrenia | Q46422863 | ||
| Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia | Q46775363 | ||
| Acute treatment with morphine augments the expression of serine racemase and D-amino acid oxidase mRNAs in rat brain | Q46780422 | ||
| P433 | issue | 6 | |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 687-702 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | Cellular Physiology and Biochemistry | Q2229420 |
| P1476 | title | Molecular mechanisms of schizophrenia | |
| P478 | volume | 20 |
| Q34393037 | 22q11 deletion syndrome: a review of the neuropsychiatric features and their neurobiological basis |
| Q47763251 | A Protocol for Producing the Maternal Low-Protein Rat Model: A Tool for Preclinical Proteomic Studies |
| Q34345562 | A common neuronal response to alphaherpesvirus infection |
| Q33531348 | A novel microRNA and transcription factor mediated regulatory network in schizophrenia |
| Q42437288 | A schizophrenia-linked mutation in PIP5K2A fails to activate neuronal M channels |
| Q35760215 | Abnormal activity of the MAPK- and cAMP-associated signaling pathways in frontal cortical areas in postmortem brain in schizophrenia |
| Q39928385 | Age of Onset in Schizophrenia Spectrum Disorders: Complex Interactions between Genetic and Environmental Factors |
| Q30409979 | Altered serine/threonine kinase activity in schizophrenia |
| Q28591808 | Altered social behavior and neuronal development in mice lacking the Uba6-Use1 ubiquitin transfer system |
| Q50309747 | An in Silico, Biomarker-Based Method for the Evaluation of Virtual Neuropsychiatric Drug Effects |
| Q30386608 | Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection |
| Q42231418 | Association between Interleukin 31 Receptor A Gene Polymorphism and Schizophrenia in Korean Population |
| Q88022657 | Association between PLA2G12A polymorphism and patients with schizophrenia in a southern Chinese Han population |
| Q50655624 | Association between the angiotensin-converting enzyme gene insertion/deletion polymorphism and first-episode patients with schizophrenia in a Chinese Han population. |
| Q48126921 | Association between two single nucleotide polymorphisms at corresponding microRNA and schizophrenia in a Chinese population. |
| Q50853508 | Association of BDNF gene polymorphisms with schizophrenia and clinical symptoms in a Chinese population. |
| Q45363282 | Association of GRIN1 and GRIN2A-D with schizophrenia and genetic interaction with maternal herpes simplex virus-2 infection affecting disease risk |
| Q34078251 | Association study between a polymorphism at the 3'-untranslated region of CLOCK gene and attention deficit hyperactivity disorder |
| Q49126111 | Association study of GRIK1 gene polymorphisms in schizophrenia: case-control and family-based studies |
| Q46118805 | Association study of clock gene (CLOCK) and schizophrenia and mood disorders in the Japanese population |
| Q48313856 | Associations between use of cocaine, amphetamines, or psychedelics and psychotic symptoms in a community sample |
| Q37069020 | Biomarkers in Psychiatry - A Critique |
| Q92580016 | Brain-Derived Neurotropic Factor Serum Level and Severity Symptom of Bataknese Male Patients with Schizophrenia in North Sumatera, Indonesia |
| Q35847085 | Brain-derived neurotrophic factor and neuropsychiatric disorders |
| Q43928105 | Case-control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population. |
| Q30090165 | Caveolin-1 Sensitivity of Excitatory Amino Acid Transporters EAAT1, EAAT2, EAAT3, and EAAT4. |
| Q44960454 | Clozapine and N-Methyl-d-Aspartate have positive modulatory actions on their respective discriminative stimulus properties in C57BL/6 mice |
| Q90415757 | Cognitive Enhancing Effect of High-Frequency Neuronavigated rTMS in Chronic Schizophrenia Patients With Predominant Negative Symptoms: A Double-Blind Controlled 32-Week Follow-up Study |
| Q38124448 | Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings |
| Q33420372 | Comparison of gene expression profile in embryonic mesencephalon and neuronal primary cultures |
| Q47679011 | Corticostriatal circuit defects in Hoxb8 mutant mice |
| Q21129280 | Cotinine: Beyond that Expected, More than a Biomarker of Tobacco Consumption |
| Q47788549 | Development of patient-specific neurons in schizophrenia using induced pluripotent stem cells |
| Q33374181 | Developmental disruptions in neural connectivity in the pathophysiology of schizophrenia |
| Q48572492 | Down-Regulation of Excitatory Amino Acid Transporters EAAT1 and EAAT2 by the Kinases SPAK and OSR1. |
| Q92732345 | Downregulated AKT-mTOR signaling pathway proteins in dorsolateral prefrontal cortex in Schizophrenia |
| Q24316880 | Effect of ligand binding on human D-amino acid oxidase: implications for the development of new drugs for schizophrenia treatment |
| Q27333743 | Emerging roles of ARHGAP33 in intracellular trafficking of TrkB and pathophysiology of neuropsychiatric disorders. |
| Q38672722 | Employing proteomics to unravel the molecular effects of antipsychotics and their role in schizophrenia |
| Q39315740 | Expression and methylation of BDNF in the human brain in schizophrenia |
| Q38508234 | Gene- and evidence-based candidate gene selection for schizophrenia and gene feature analysis |
| Q47684050 | Genetic and Functional Analysis of GRIN2A in Tumor Samples. |
| Q33560765 | Genetic and brain structure anomalies in autism spectrum disorders. Towards an understanding of the aetiopathogenesis? |
| Q46397571 | Genetic association analysis of tagging SNPs in alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes (CHRNA4 and CHRNB2) with schizophrenia in the Japanese population |
| Q33729022 | Genetics of schizophrenia from a clinicial perspective. |
| Q33928389 | Genome-wide association identifies candidate genes that influence the human electroencephalogram |
| Q24655879 | Genome-wide association study of anthropometric traits in Korcula Island, Croatia |
| Q37473779 | Group II metabotropic glutamate receptors and schizophrenia |
| Q35149520 | Heat shock alters the expression of schizophrenia and autism candidate genes in an induced pluripotent stem cell model of the human telencephalon |
| Q24624921 | Hematopoietic origin of pathological grooming in Hoxb8 mutant mice |
| Q37138150 | Heritability and genome-wide SNP linkage analysis of temperament in bipolar disorder |
| Q51351780 | Homodimerization enhances both sensitivity and dynamic range of the ligand-binding domain of type 1 metabotropic glutamate receptor. |
| Q47555364 | Identifying and exploiting trait-relevant tissues with multiple functional annotations in genome-wide association studies |
| Q39144681 | Immersion in altered experience: An investigation of the relationship between absorption and psychopathology |
| Q33678807 | Impact of the AHI1 gene on the vulnerability to schizophrenia: a case-control association study |
| Q30457731 | Ion channels and schizophrenia: a gene set-based analytic approach to GWAS data for biological hypothesis testing |
| Q34907600 | Klotho sensitivity of the neuronal excitatory amino acid transporters EAAT3 and EAAT4. |
| Q43063737 | Lack of association between MAGEL2 and schizophrenia and mood disorders in the Japanese population |
| Q38989183 | MIR137 variants identified in psychiatric patients affect synaptogenesis and neuronal transmission gene sets |
| Q35598966 | MK-801 treatment affects glycolysis in oligodendrocytes more than in astrocytes and neuronal cells: insights for schizophrenia |
| Q37810163 | Metabonomic studies of schizophrenia and psychotropic medications: focus on alterations in CNS energy homeostasis |
| Q37368965 | MicroRNAs in mental health: from biological underpinnings to potential therapies |
| Q59697660 | Microarray comparative genomic hybridization analysis of 59 patients with schizophrenia |
| Q34137363 | Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia |
| Q36170150 | Molecular pathways: dysregulated glutamatergic signaling pathways in cancer |
| Q26853035 | Molecular underpinnings of prefrontal cortex development in rodents provide insights into the etiology of neurodevelopmental disorders |
| Q33749231 | NMDA Receptor Hypofunction Induces Dysfunctions of Energy Metabolism And Semaphorin Signaling in Rats: A Synaptic Proteome Study |
| Q37309811 | Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome |
| Q28285114 | Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway |
| Q35262436 | Neurotrophins regulate ApoER2 proteolysis through activation of the Trk signaling pathway |
| Q42114745 | Noise as a mechanism of anomalous face processing among persons with Schizophrenia |
| Q39818618 | PIP5K2A-dependent regulation of excitatory amino acid transporter EAAT3. |
| Q35150392 | Parallel mRNA and microRNA profiling of HEV71-infected human neuroblastoma cells reveal the up-regulation of miR-1246 in association with DLG3 repression |
| Q36595706 | Parasynaptic NMDA receptor signaling couples neuronal glutamate transporter function to AMPA receptor synaptic distribution and stability |
| Q43962534 | Partial support for ZNF804A genotype-dependent alterations in prefrontal connectivity |
| Q55000492 | Perinatal Hypoxia and Ischemia in Animal Models of Schizophrenia. |
| Q48334300 | Proteomic analysis of the maternal protein restriction rat model for schizophrenia: identification of translational changes in hormonal signaling pathways and glutamate neurotransmission |
| Q28284253 | Psychiatric genetics: progress amid controversy |
| Q24608775 | Rare structural variation of synapse and neurotransmission genes in autism |
| Q37800115 | Role of immune molecules in the establishment and plasticity of glutamatergic synapses |
| Q37633791 | Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action |
| Q37251394 | SNAP-25 in neuropsychiatric disorders |
| Q37862242 | Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment |
| Q24317440 | Significance of SGK1 in the regulation of neuronal function |
| Q37272524 | Small molecule protein-protein interaction inhibitors as CNS therapeutic agents: current progress and future hurdles. |
| Q34051230 | Somatic mutation of GRIN2A in malignant melanoma results in loss of tumor suppressor activity via aberrant NMDAR complex formation |
| Q42156149 | Structural and functional impairments of polysialic acid by a mutated polysialyltransferase found in schizophrenia |
| Q50217150 | Sub-chronic Antipsychotic Drug Administration Reverses the Expression of Neuregulin 1 and ErbB4 in a Cultured MK801-Induced Mouse Primary Hippocampal Neuron or a Neurodevelopmental Schizophrenia Model |
| Q50440080 | Synaptic NMDA Receptor Activation Induces Ubiquitination and Degradation of STEP61. |
| Q36492240 | Synaptic underpinnings of altered hippocampal function in glutaminase-deficient mice during maturation |
| Q38770356 | Targeting Retinoid Receptors to Treat Schizophrenia: Rationale and Progress to Date. |
| Q42749859 | The dopamine and cAMP regulated phosphoprotein, 32 kDa (DARPP-32) signaling pathway: a novel therapeutic target in traumatic brain injury |
| Q37800023 | The dual role of the extracellular matrix in synaptic plasticity and homeostasis |
| Q89727376 | The ubiquitin proteasome system and schizophrenia |
| Q56768394 | Toxoplasmosis |
| Q38168821 | Transcription factor and microRNA co-regulatory loops: important regulatory motifs in biological processes and diseases |
| Q89421779 | Two distinct ontogenies confer heterogeneity to mouse brain microglia |
| Q33933939 | Two four-marker haplotypes on 7q36.1 region indicate that the potassium channel gene HERG1 (KCNH2, Kv11.1) is related to schizophrenia: a case control study |
| Q33707718 | Whole-exome sequencing of individuals from an isolated population implicates rare risk variants in bipolar disorder |
| Q47073898 | Zebrafish rgs4 is essential for motility and axonogenesis mediated by Akt signaling |
| Q39038756 | mRNA Expression and DNA Methylation Analysis of Serotonin Receptor 2A (HTR2A) in the Human Schizophrenic Brain |
Search more.